ATRIUM MEDICAL CORPORATION
Manufacturer adverse-event records for ATRIUM MEDICAL CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1997–2026 · thin-book · elevated Death-code · injury-heavy
Injury-mix signature
ATRIUM MEDICAL CORPORATION leans injury-heavy in event_type mix
Injury-coded event_type share is 83.0% (injury-heavy tercile) beside 1.39% Death-coded (elevated). Volume band: thin.
What the Injury-mix reading shows for ATRIUM MEDICAL CORPORATION
The standout signal for ATRIUM MEDICAL CORPORATION is Injury-mix: 83.0% Injury-coded (injury-heavy) beside 1.39% Death-coded, on a thin-book footprint.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 18 device types, led in this extract by Injury at 4,947 (83.0% of event_type total). Peak single-year volume reaches 1,480 reports across 25 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (18)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.